Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations.

RMD open·2026

Same author

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026

Same author

Retention Rates of Biological Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Reduced Kidney Function: Analysis From the IORRA Cohort.

International journal of rheumatic diseases·2026

Same author

Humidifier lung and summer-type hypersensitivity pneumonitis in Japan: a nationwide retrospective observational study of clinical, radiological and pathological features.

BMJ open respiratory research·2026

Same author

Medical pre-training and fine-tuning improve large-language-model prediction of rheumatoid-arthritis disease activity.

Modern rheumatology·2026

Same author

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study.

Rheumatology (Oxford, England)·2026

Search research articles

Related Experiment Video

Updated: Oct 4, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives.

Masashi Bando¹, Sakae Homma², Masayoshi Harigai³

¹Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan.

Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG

|February 4, 2022

Summary

Microscopic polyangiitis (MPA) can cause interstitial pneumonia. This review explores the link between myeloperoxidase (MPO)-ANCA positive interstitial pneumonia and MPA, addressing diagnostic challenges.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

Related Experiment Videos

Last Updated: Oct 4, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

Area of Science:

Pulmonary Medicine
Rheumatology
Immunology

Background:

Interstitial pneumonia is a significant respiratory complication in microscopic polyangiitis (MPA).
The precise pathogenesis of interstitial pneumonia during MPA's clinical course remains understudied.
Myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA) positive interstitial pneumonia is increasingly recognized as a potential precursor to MPA.

Purpose of the Study:

To review the clinical questions surrounding MPO-ANCA positive interstitial pneumonia.
To summarize current evidence regarding the relationship between MPO-ANCA positive interstitial pneumonia and ANCA-associated vasculitis (AAV).
To identify gaps in knowledge and future research directions.

Main Methods:

Literature review of existing studies on MPA, interstitial pneumonia, and ANCA.
Analysis of clinical data and diagnostic criteria related to MPO-ANCA positive interstitial pneumonia.
Discussion of expert opinions and consensus among pulmonologists and rheumatologists.

Main Results:

Interstitial pneumonia is a key feature in MPA, but its specific development pathway within MPA is not well understood.
A subset of patients with MPO-ANCA positive interstitial pneumonia may develop MPA, though the incidence and diagnostic criteria are debated.
There is ongoing debate regarding the classification of MPO-ANCA positive interstitial pneumonia without other organ involvement as a form of AAV.

Conclusions:

Further research is needed to elucidate the pathogenesis of interstitial pneumonia in MPA.
Establishing clear diagnostic criteria for MPO-ANCA positive interstitial pneumonia is crucial for accurate classification and management.
Collaboration between pulmonologists and rheumatologists is essential to address the diagnostic and classification challenges of MPO-ANCA positive interstitial pneumonia in the context of AAV.